Header cover image

Hong Kong (HSI) Pharma Industry Analysis

UpdatedJan 19, 2022
DataAggregated Company Financials
  • 7D0.1%
  • 3M0.4%
  • 1Y-20.6%
  • YTD0.6%

Over the last 7 days, the Pharma industry has remained flat, although notably CSPC Pharmaceutical Group gained 5.2%. As for the longer term, the industry has declined 21% in the last year.

Industry Valuation and Performance

Has the Hong Kong Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Thu, 20 Jan 2022HK$747.1bHK$497.5bHK$43.9b9.8x
Sat, 18 Dec 2021HK$684.2bHK$497.1bHK$43.8b8.7x
Mon, 15 Nov 2021HK$677.1bHK$495.8bHK$43.4b9.5x
Wed, 13 Oct 2021HK$728.7bHK$490.1bHK$42.5b9.9x
Fri, 10 Sep 2021HK$812.6bHK$489.5bHK$42.4b11.6x
Sun, 08 Aug 2021HK$920.7bHK$489.5bHK$42.4b11.7x
Sat, 01 May 2021HK$986.8bHK$463.7bHK$30.0b13.9x
Tue, 02 Feb 2021HK$887.6bHK$438.9bHK$27.7b12.2x
Fri, 06 Nov 2020HK$815.3bHK$424.8bHK$27.3b13.3x
Mon, 10 Aug 2020HK$866.8bHK$407.8bHK$27.1b18x
Sun, 03 May 2020HK$706.9bHK$416.7bHK$27.5b16x
Wed, 05 Feb 2020HK$716.1bHK$429.4bHK$27.1b13.3x
Sat, 09 Nov 2019HK$722.8bHK$416.3bHK$34.1b12.2x
Fri, 02 Aug 2019HK$659.8bHK$414.0bHK$34.7b11.9x
Mon, 06 May 2019HK$573.4bHK$390.8bHK$32.8b13.9x
Thu, 07 Feb 2019HK$509.7bHK$363.6bHK$31.7b14.5x
PE Ratio


Total Market Cap: HK$509.7bTotal Earnings: HK$31.7bTotal Revenue: HK$363.6b0%0%0%3 Year10 Year

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 13.1x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 11% per year over the last three years, and revenues for these companies have grown 11% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Hong Kong Pharma industry?


Industry PE: Investors are most optimistic about the Pharma industry even though it's trading below its 3-year average PE ratio of 13.1x. However analysts are expecting annual earnings growth of 8.9%, which is lower than the prior year's growth of 24% per year. So the market might believe that analysts are underestimating future growth.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 8.9% over the next 5 years. However this is lower than its past earnings growth rate of 24% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1093 CSPC Pharmaceutical GroupHK$9.725.2%
2096 Simcere Pharmaceutical GroupHK$10.4012.3%
1558 YiChang HEC ChangJiang PharmaceuticalHK$7.5213.9%
3933 United Laboratories International HoldingsHK$4.754.4%
512 Grand Pharmaceutical GroupHK$6.501.4%
Simply Wall St™
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News



CanSino Biologics







SSY Group







Hansoh Pharmaceutical Group